The majority of deaths from advanced, difficult-to-treat cancers are a result of metastases. Programmed death 1 ligand (PD-L1), a negative regulator of the immune system, is highly expressed in metastatic cancer cells, and its expression is associated with suppressed anti-tumour immunity.
Read more